InvestSMART

Zoono Group Limited (ASX:ZNO)

ALERT: Price-sensitive ASX Announcement for ZNO
Current share price for ZNO : $0.050 -0.024 (-32.43%)+
Announcement
Release
14 Apr 2026 11:36AM
Price at Release
$0.074
Full Release
download
Summary
Zoono Group Limited, an antimicrobial solution company, released its Appendix 4C report for the quarter ending 31 March 2026. The company reported increased cash receipts by NZ$333K due to new partnerships in packaging manufacturing. Zoono focuses on niche markets like fresh food shelf-life extension and is seeing progress in sales opportunities, expecting further orders and cash receipts. The cash flow statement shows net cash used in operations of NZ$183K for the current quarter, with cash equivalents standing at NZ$307K by quarter-end. Related party payments amounted to NZ$110K for director fees. Despite operating cash flow challenges, Zoono expects to continue its operations based on reduced overheads and anticipated customer receipts in the coming quarters. The company is open to raising further cash if required to ensure operational funding.
Key Points
  • Zoono Group Limited released its Appendix 4C for Q1 2026.
  • Cash receipts increased by NZ$333K due to new packaging partners.
  • Focus on fresh food shelf-life extension in markets like UK, Europe, Asia.
  • Net cash used in operations for the quarter was NZ$183K.
  • Cash equivalents at quarter-end were NZ$307K.
  • Related party payments amounted to NZ$110K for director fees.
  • Zoono expects to continue operations with future orders and reduced overheads.
  • The company may raise further cash if needed for operations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.